TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Argent Biopharma ( (AU:RGT) ) is now available.
Argent Biopharma Limited has announced a proposed issuance of securities, including 21,950,952 unlisted options and 11,000,000 convertible notes, set to commence on December 1, 2025. This strategic financial move is expected to bolster the company’s capital structure, potentially enhancing its market position and providing additional resources for ongoing and future projects, thereby impacting stakeholders positively.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative medical treatments. The company is involved in the research and production of pharmaceutical products aimed at addressing unmet medical needs.
YTD Price Performance: -55.29%
Average Trading Volume: 122,137
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.91M
See more data about RGT stock on TipRanks’ Stock Analysis page.